Hepatitis C virus non-structural 5A abrogates signal transducer and activator of transcription-1 nuclear translocation induced by IFN-alpha through dephosphorylation.
OBJECTIVE
To study the effect of Hepatitis C virus non-structural 5A (HCV NS5A) on IFNalpha induced signal transducer and activator of transcription-1 (STAT1) phosphorylation and nuclear translocation.


METHODS
Expression of STAT1 Tyr701 phosphorylation at different time points was confirmed by Western blot, and the time point when p-STAT1 expressed most, was taken as the IFN induction time for further studies. Immunocytochemistry was used to confirm the successful transient transfection of NS5A expression plasmid. Immunofluorescence was performed to observe if there was any difference in IFNalpha-induced STAT1 phosphorylation and nuclear translocation between HCV NS5A-expressed and non-HCV NS5A-expressed cells. Western blot was used to compare the phosphorylated STAT1 protein of the cells.


RESULTS
Expression of HCV NS5A was found in the cytoplasm of P(CNS5A-transfected ) Huh7 cells, but not in the PRC/CMV transfected or non-transfected cells. STAT1 Tyr701 phosphorylation was found strongest in 30 min of IFN induction. STAT1 phosphorylation and nuclear import were much less in the presence of HCV NS5A protein in contrast to P( RC/CMV-transfected ) and non-transfected cells under fluorescent microscopy, which was further confirmed by Western blot.


CONCLUSIONS
HCV NS5A expression plasmid is successfully transfected into Huh7 cells and HCV NS5A protein is expressed in the cytoplasm of the cells. IFN-alpha is able to induce STAT1 phosphorylation and nuclear translocation, and this effect is inhibited by HCV NS5A protein, which might be another possible resistance mechanism to interferon alpha therapy.
Gong
Guo-Zhong
GZ
Institute of Hepatology and Department of Infectious Diseases, The Second Xiangya Hospital, Central South University, Changsha 410011, Hunan Province, China. guozhonggong@yahoo.com
Cao
Jie
J
Jiang
Yong-Fang
YF
Zhou
Yang
Y
Liu
Bo
B
D000998:Antiviral Agents / Q000627:therapeutic use*; D045744:Cell Line, Tumor; D024882:Drug Resistance, Viral / Q000502:physiology; D016174:Hepacivirus / Q000187:drug effects / Q000502:physiology; D006526:Hepatitis C / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D010766:Phosphorylation / Q000187:drug effects; D010957:Plasmids; D011994:Recombinant Proteins; D050794:STAT1 Transcription Factor / Q000378:metabolism*; D015398:Signal Transduction / Q000502:physiology*; D014162:Transfection; D017361:Viral Nonstructural Proteins / Q000502:physiology*; D012324:RNA-Dependent RNA Polymerase
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D050794:STAT1 Transcription Factor; D017361:Viral Nonstructural Proteins; C494079:STAT1 protein, human; C087036:NS-5 protein, hepatitis C virus; D012324:RNA-Dependent RNA Polymerase
Proc Natl Acad Sci U S A. 1999 May 11;96(10):5533-8
10318918
Eur J Biochem. 1997 Sep 15;248(3):615-33
9342212
J Gen Virol. 1997 Oct;78 ( Pt 10):2397-410
9349458
Pathol Biol (Paris). 2004 Nov;52(9):505-10
15531113
J Hepatol. 2007 May;46(5):759-67
17275127
Virology. 1997 Apr 14;230(2):217-27
9143277
J Virol. 1995 Jul;69(7):3980-6
7769656
J Virol. 2006 Jun;80(12 ):5908-18
16731929
J Virol. 2005 Oct;79(20):12828-39
16188985
Cell Death Differ. 2003 Jan;10 Suppl 1:S27-38
12655344
Virology. 2002 Aug 1;299(2):164-71
12202219
Cell. 1995 Jul 28;82(2):241-50
7543024
Gastroenterology. 2005 Apr;128(4):1034-41
15825084
Sci STKE. 2003 Aug 12;2003(195):RE13
12915721
Proc Natl Acad Sci U S A. 2001 Aug 14;98(17):9599-604
11481452
J Gen Virol. 2004 Apr;85(Pt 4):959-69
15039538
Science. 1999 Jul 2;285(5424):107-10
10390359
J Biol Chem. 1997 Sep 26;272(39):24542-9
9305919
J Med Virol. 2004 Aug;73(4):536-47
15221897
Dig Dis Sci. 2002 Jun;47(6):1195-205
12064791
Science. 2003 May 16;300(5622):1145-8
12702807
J Clin Invest. 1995 Jul;96(1):224-30
7542279
Viral Immunol. 2002;15(1):95-119
11952150
Mol Cell Biol. 1997 Nov;17(11):6508-16
9343414
J Gen Virol. 2004 Sep;85(Pt 9):2485-502
15302943
Microbiol Immunol. 2001;45(12):829-40
11838900